Want to join the conversation?
$AMGN and $ARWR announced two agreements to develop and commercialize RNA interference (RNAi) therapies for cardiovascular disease. Under one agreement, $AMGN receives a worldwide, exclusive license to $ARWR's RNAi ARC-LPA program. These RNAi molecules are designed to reduce elevated lipoprotein, which is a risk factor for cardiovascular disease.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!